Posts Tagged ‘Thailand’

Best 2012 Destinations: National Geographic Finds Something for Everyone

Thursday, November 17th, 2011 by

If you are planning your next international trip, it will likely be a 2012 event. In anticipation, National Geographic Traveler magazine has tapped twenty destinations as Best of the World 2012. There’s something for everyone, and they all hold promise for improving mind, body and spirit for those who make the trip. You can visit the picture gallery online to be inspired. I took the liberty of classifying the destinations as a way to highlight and summarize the experiences that await you. It’s a terrific list.

Hitting Healthy Travel Blog Themes
Colombia–Ciudad Perdida:  Hiking
Greece–Kardamili:  Slow Tourism
Panama– Coiba National Park:  Eco-tourism
Peru –Lima:  Mistura food festival
Rwanda/Congo–Virunga:  Volcanoes
Sri Lanka– Nuwara Eliya:  New UNESCO World Heritage site

Rebirth
Germany—Dresden:  Historic city center rebuilt
Northern Ireland—Belfast:  Titanic quarter
United States—Pittsburgh: Sustainable design

Over the Top?
Croatia—Istria:  Romance
Oman—Muscat:  Luxury
Thailand—Koh Lipe:  Island paradise

Cultural Discoveries
Guatemala—Chichicastenango:  Mayan
Spain—Girona:  Catalan 

Rugged Outdoors
Iceland—Snaefellsnes Peninsula: Primeval
Mongolia—Hovsgol:  Recreational taiga
New Zealand—Rotorua:  Geothermal

Familiar But Special
Canada—Muskoka: Lake cottages
United Kingdom—London: Olympics
United States—Sonoma: More than wine

Have you visited any of these locations? Are there any destinations you would recommend?

Share

Travel Bulletin Asia: Parts of Asia and the Indian Ocean Region Report Cases of Chikungunya Fever

Monday, October 18th, 2010 by

According to a recent report from the Centers for Disease Control (CDC), chikungunya fever continues to be active in Asia and the Indian Ocean region:

In 2009, the Ministry of Health in Malaysia reported over 4,430 cases of chikungunya fever. No deaths were reported. The most affected areas were the northern provinces of Sarawak Kedah, followed by Kelantan, Selangor, and Perak. Chikungunya fever activity has decreased in 2010. As of August 28, there are an additional 751 reported cases, which have occurred predominately in Sarawak and Saba provinces.

During 2009, Thailand reported 49,069 cases of chikungunya fever. Limited chikungunya activity has continued in 2010. Most cases have been reported in the south of the country. As of August 31, 2010, India has reported 16,870 suspected cases from 14 states. The majority of cases were from Karnataka, Maharashtra, Tamil Nadu, Kerala, and Gujarat states. In 2009, over 43,000 cases were also reported in Indonesia.

Limited chikungunya activity continues in the French island of Reunion. As of September 1, 2010, 110 confirmed and 38 probable cases of chikungunya were reported. Most of the cases have been identified in the western commune of Saint-Paul. Health authorities have increased surveillance for chikungunya on the island.

Advice for Travelers

No medications or vaccines are available to prevent a person from getting sick with chikungunya fever. CDC recommends that people traveling to areas where chikungunya fever has been reported take the following steps to protect themselves from mosquito bites.

- When outdoors or in a building that is not well screened, use insect repellent on uncovered skin. If sunscreen is needed, apply before insect repellent.

- Look for a repellent that contains one of the following active ingredients: DEET, picaridin (KBR 3023), Oil of Lemon Eucalyptus/PMD, or IR3535. Always follow the instructions on the label when you use the repellent.

- In general, repellents protect longer against mosquito bites when they have a higher concentration (%) of any of these active ingredients. However, concentrations above 50% do not offer a distinct increase in protection time. Products with less than 10% of an active ingredient may offer only limited protection, often only 1–2 hours.

- The American Academy of Pediatrics approves the use of repellents with up to 30% DEET on children over 2 months of age.

- Protect babies less than 2 months old by using a carrier draped with mosquito netting with an elastic edge for a tight fit.

- Wear loose, long-sleeved shirts and long pants when outdoors.

- For greater protection, clothing may also be sprayed with repellent containing permethrin or another EPA-registered repellent. (Remember: don’t use permethrin on skin.)

If you get sick with a fever and think you may have chikungunya fever, you should seek medical care. Although there is no specific treatment for the disease, a doctor may be able to help treat your symptoms. Avoid getting any other mosquito bites, because if you are sick and a mosquito bites you, it can spread the disease to other people.

 Copyright © 2010, Centers for Disease Control and Prevention

Share

Dengue Fever Takes Hold in Thailand

Thursday, September 16th, 2010 by

More evidence that the incidence of dengue fever is swelling significantly around the world:  since January, Thailand has recorded almost 71,000 cases–more than double the amount this time last year.

The World Health Organization has spoken out, asking the Thai government to increase its efforts to minimize the spread of the disease. According to the Bangkok Post, efforts to eradicate “breeding grounds for mosquito larvae like unsanitary pools, stagnant water, abandoned potted plants and automobile tires around the home, still need to be strengthened in communities, particularly urban areas prone to the disease.”

We continue to track the wave of dengue across Africa, the South Pacific, Central and South America, the Caribbean, the Middle East, and now Asia. If you are traveling to any of these areas, be vigilant: protect yourself from the bites of mosquitoes.

Photo by wise_kwai.

Share

Mosquitoes — Delivering Dengue, Malaria and Chikungunya

Friday, June 18th, 2010 by

Mosquitoes continue to do the dirty work of spreading dengue fever, malaria and chikungunya virus to people in clustered areas around the world. The rainy seasons and the weather patterns of the past six months have enabled the mosquitoes to breed and spread the viruses that can leave the recipients extremely ill or even dead.

Venezuela seems to be the hardest hit country at this point. They reported 22,880 cases of malaria and 38,174 cases of dengue fever in the past five months.   

The dengue outbreak in Sri Lanka has been so severe that in the capital, Colombo, the Ministry of Health is inspecting homes and public buildings for possible mosquito breeding grounds and spraying pesticides in at-risk areas. 

Because of the monsoon rains that poured down throughout India’s summer (March to May), several cases of dengue and chikungunya are being reported from there.  Also, numerous cases of chikungunya are being reported from Malaysia, Thailand and the French island of Reunion.

If you are traveling to any of these areas, protect yourself from mosquitoes! For destination or disease specific information, there are plenty of resources available on the Centers for Disease Control and Prevention website.

Photo by Marshall Astor.

Share

Eyes Wide Shut? Know Your Destination’s Human Rights Record

Tuesday, June 15th, 2010 by

We’ve linked tolerance with health in the past. Now the unexpected outburst of ethnic violence in the Kyrgyz Republic is a vivid reminder of how tenuous the grip we humans have on tolerance, dignity, survival and health. With the Kyrgyz atrocities as a backdrop, the U.S. State Department yesterday released its annual report on human trafficking around the world, highlighting especially those countries whose efforts fall far short of complying with the U.S. Trafficking Victims Protection Act of 2000. Of the 177 countries surveyed (including the U.S.), fifty six, or 32%, are on a watch list because recent progress toward compliance is deemed at risk. Another thirteen, or 7%, are making no compliance efforts whatsoever. The remaining 60% are either in compliance or moving steadily in that direction. See charts below for a listing of countries falling into these categories and see the State Department’s interactive map and the full report.

As our readers circle the globe, we hope they pause to understand their host countries’ human rights record. There are unpleasant realities in many destinations, and some surprises for me in the Caribbean, Central America and Asia. Even developed countries such as Russia, Singapore and Thailand are called out. We aren’t suggesting you should avoid travel to these countries. We are recommending that as your horizons expand they encompass a commitment to promoting tolerance and dignity. We will all be healthier for it.

Share

New Japanese Encephalitis Vaccine Reduces Side Effects

Wednesday, May 19th, 2010 by

Good news for travelers throughout Asia.  There is a new vaccine against Japanese encephalitis that significantly reduces typical side effects.

We all know that mosquitoes transmit some very serious viruses to humans. In addition to malaria and dengue fever, another mosquito-driven disease is Japanese encephalitis virus (JEV).  As reported by the World Health Organization (WHO) JEV is endemic in parts of China, India, the Republic of Korea, Japan, the Russian Federation, islands in the Torres Strait of Australia, Nepal, Thailand, Viet Nam, Cambodia, the Lao People’s Democratic Republic, the Philippines, Taiwan, Indonesia, Malaysia, and Sri Lanka. Its breakouts are generally most prevalent during the summer and fall.

There is no treatment available for this disease which can lead to permanent damage to the nervous system or death. Though many vacationers or expats will not find themselves in high-risk areas during peak times, it is recommended by the Centers for Disease Control (CDC) that anyone travelling to an endemic area during a possible transmission season or those who are headed toward a potentially dangerous area should be vaccinated for JEV.

Historically, the vaccine was toxic to some people — especially those with a history of allergy to wasp/bee stings.  Many doctors were hesitant to give the traditional vaccine and if they did, they would advise recipients to stay in a country with decent medical facilities in case they were one of the rare cases to develop an allergic reaction within 10 days of receiving the vaccine.  Fortunately for those over 18 years of age, there is now a new vaccine that does not cause those side-effects and can be given as safely as any of our other vaccines.

In summary: If you are over 18 years old and travelling to one of the high risk areas mentioned above, ask your doctor for the new non-allergic Japanese encephalitis vaccine.

Author: Charlie Easmon, MBBS
Charlie Easmon, MBBS is a General Practitioner whose practice has a strong focus on Travel Medicine.  He is a Regional Physician Advisor for HTH Worldwide and the Medical Director for The Number One Health Group on Harley Street in London and ALC Global Health Insurance.  He is a member of the Royal College of Physicians, UK and has a Diploma in Tropical Medicine and Hygiene from the University of Liverpool.   Dr. Easmon is an Honorary Lecturer at the London School of Hygiene and Tropical Medicine. 

Share

Means to End Chikungunya Menace? Report Raises Hope

Friday, February 19th, 2010 by

New Scientist magazine is reporting a scientific advance that may hold the key to defeating  a mosquito-borne virus that turned dangerous and deadly and has been spreading across the world for the past five years. Carried by the tiger mosquito and driven by the forces of global commerce, chikungunya  virus causes fever, headache, nausea as well as excruciating pain in smaller joints, earning it the nickname “knuckle fever.”  This virulent form first appeared in the islands of the Indian Ocean but has since invaded every continent by way of airports and sea ports.   The CDC highlights some specific reports of recent activity in Indonesia, Thailand and Malaysia on their website, where they also offer advice to clinicians and travelers. 

Now the U.S.  National Institutes of Health (NIH) are reporting a breakthrough in the search for a vaccine by using genetic engineering to create virus-like particles which perfectly mimic the virus without being infectious. Tests with Rhesus monkeys have shown the vaccine to be completely effective against chikungunya. Testing in humans is likely to begin in one to three years.

The NIH’s work with chikungunya  may have ushered in a new era of vaccine production that could prove to be safer and more effective than the many live virus vaccines that are in use today.  It may only be a matter of time before vaccines created from pieces of viruses will replace those derived from whole, live viruses. Diseases such as Kala Azar, sleeping sickness and Dengue fever that afflict travelers to tropical regions do not currently have effective vaccines.  In principle, the creation of vaccines from virus like particles could someday eliminate that problem.

Photo info: http://www.flickr.com/photos/deadmike/ / CC BY-NC-SA 2.0

Share